Michael W. Bonney - Jun 30, 2021 Form 4 Insider Report for Kaleido Biosciences, Inc. (KLDO)

Role
Director
Signature
/s/ Jerald Korn, as Attorney-in-Fact
Stock symbol
KLDO
Transactions as of
Jun 30, 2021
Transactions value $
$0
Form type
4
Date filed
7/1/2021, 04:25 PM
Previous filing
Jun 14, 2021
Next filing
Jul 19, 2021

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction KLDO Stock Option (Right to Buy) Award $0 +15K $0.00 15K Jun 30, 2021 Common Stock 15K $7.44 Direct
transaction KLDO Stock Option (Right to Buy) Award $0 +15K $0.00 15K Jun 30, 2020 Common Stock 15K $7.43 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The original Form 4, filed on July 1, 2020, is being amended by this Form 4 amendment solely to correct an administrative error, which misreported the exercise price as $7.42 when in fact the exercise price is 7.43.